Home LiteratureArticle Details
PMID: 5543879 Published · ppublish English Journal Article

Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

The Journal of clinical investigation ·Vol. 50 ·No. 1 ·1971-01-00 ·Pages 244-54

Zimmerman TS, Ratnoff OD, Powell AE

Abstract

Heterologous antiserum was prepared in rabbits against highly purified human antihemophilic factor (AHF, factor VIII). This antiserum blocked the clot-promoting properties of AHF and, when suitably absorbed, formed a single precipitin line against AHF upon immunoelectrophoresis. Material antigenically similar to normal AHF was detected in normal amounts in plasma concentrates in each of 22 patients with classic hemophilia, in a patient with an acquired circulating anticoagulant against AHF, and in a patient with deficiencies both of AHF and proaccelerin (factor V). AHF-like antigen was present in normal human serum. In contrast, material antigenically related to AHF was found in decreased amounts in the concentrates prepared from the plasma of 11 patients with von Willebrand's disease. The experiments described suggest that von Willebrand's disease is a disorder in which a true deficiency of AHF exists. Whether the AHF-like material found in classic hemophilia is nonfunctional through a defect in structure or through the intervention of an inhibitor has not been shown.

MeSH Terms
Animals Anticoagulants Antigen-Antibody Reactions Antigens Blood Coagulation Tests Diagnosis, Differential
Chemicals
Anticoagulants Antigens
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Zimmerman T S
Ratnoff O D
Powell A E
References (27)
27 references, click to expand
  1. Two types of haemophilia (A+ and A-): a study of 48 cases.
    Br J Haematol. 1969 Aug;17(2):163-71 PMID: 5306640
  2. The survival of factor VIII (antihemophilic globulin) and factor IX (plasma thromboplastin component) in normal humans.
    J Clin Invest. 1963 Jul;42:1040-7 PMID: 14011051
  3. [Congenital factor V deficiency (parahemophilia) with true hemophilia in two brothers].
    Bibl Paediatr. 1954;58:575-88 PMID: 13229969
  4. Studies of cross-reactivity of acquired factor VIII inhibitor activity in hemophilic plasma.
    Thromb Diath Haemorrh. 1967 Dec 31;18(3-4):354-63 PMID: 5590233
  5. Observations on hemophilia, parahemophilia, and coexistent hemophilia and parahemophilia; alterations in the platelets and the thromboplastin generation test.
    J Lab Clin Med. 1958 Sep;52(3):449-62 PMID: 13575936
  6. The treatment of haemorrhage in von Willebrand's disease and the blood level of factor VIII (AHG).
    Br J Haematol. 1963 Apr;9:203-14 PMID: 13971121
  7. Immunization of rabbits against human anti-hemophilic factor (AHF).
    Blood. 1956 May;11(5):473-83 PMID: 13315509
  8. v. Willebrand's disease in Sweden; its pathogenesis and treatment.
    Acta Med Scand. 1959 Jun 30;164:263-78 PMID: 14427267
  9. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.
    Anal Biochem. 1966 Apr;15(1):45-52 PMID: 5959431
  10. [ANTI-FACTOR VIII CIRCULATING ANTICOAGULANTS DURING HEMOPHILIA A. (NATURE AND MECHANISM OF ACTION)].
    Nouv Rev Fr Hematol. 1963 Nov-Dec;3:703-22 PMID: 14094592
  11. [ON THE IMMUNOLOGICAL DETERMINATION OF FACTOR 8-PROTEIN IN THE BLOOD PLASMA AND ITS SIGNIFICANCE FOR THE UNDERSTANDING OF HEMOPHILIA A].
    Thromb Diath Haemorrh. 1964 Jul 31;11:423-43 PMID: 14194112
  12. ANTIBODY TO ANTIHEMOPHILIC FACTOR AND ITS LACK OF REACTION WITH HEMOPHILIC PLASMA.
    Am J Physiol. 1965 Mar;208:499-507 PMID: 14264741
  13. The immunological properties of factor VIII. II. The immunoelectrophoretic studies.
    Thromb Diath Haemorrh. 1967 Dec 31;18(3-4):325-31 PMID: 4173213
  14. Studies on the purification of antihemophilic factor (factor VIII). II. Separation of partially purified antihemophilic factor by gel filtration of plasma.
    J Clin Invest. 1969 May;48(5):957-62 PMID: 5780204
  15. Hemophilic syndromes and hemophilia.
    Blood. 1954 Mar;9(3):281-5 PMID: 13126200
  16. Studies on the conversion of prothrombin to thrombin: with notes on the cation requirement for this reaction.
    J Lab Clin Med. 1967 Feb;69(2):229-44 PMID: 6016622
  17. Activation of thromboplastinogen by thrombin.
    Am J Physiol. 1953 Jul;174(1):123-6 PMID: 13065506
  18. A circulating anticoagulant selectively active against human antihemophilic factor (autoimmune hemophilia).
    Stanford Med Bull. 1954 Nov;12(4):246-56 PMID: 13225986
  19. Immunologic studies of antihemophilic factor (AHF, factor VIII): cross-reacting material in a genetic variant of hemophilia A.
    Blood. 1968 Dec;32(6):962-71 PMID: 5303720
  20. Hemophilia A: polymorphism detectable by a factor 8 antibody.
    Science. 1969 Mar 7;163(3871):1071-2 PMID: 5764870
  21. Influence of thrombin on rate of prothrombin conversion.
    Proc Soc Exp Biol Med. 1957 Jun;95(2):207-11 PMID: 13441686
  22. Transfusion studies in von Willebrand's disease: effect on bleeding time and factor VIII.
    Br J Haematol. 1963 Apr;9:189-202 PMID: 14023112
  23. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  24. Studies of the inhibitory activity of specific antisera to some clotting factors in human plasma.
    Br J Haematol. 1962 Jul;8:204-14 PMID: 13867727
  25. Some factors that influence utilization of antihemophilic activity during clotting.
    Proc Soc Exp Biol Med. 1957 Nov;96(2):277-81 PMID: 13485079
  26. Purification of antihemophilic factor (AHF) for clinical and experimental use.
    Thromb Diath Haemorrh Suppl. 1967;26:377-81 PMID: 6064868
  27. The importance of activation of antihemophilic globulin and proaccelerin by traces of thrombin in the generation of intrinsic prothrombinase activity.
    Blood. 1963 Feb;21:221-36 PMID: 13973081
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1971-01-00
Pages
244-54
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC291913
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com